Cancer Immunology, Immunotherapy

, Volume 53, Issue 3, pp 139–143

Identification of tumour antigens by serological analysis of cDNA expression cloning

Review

Abstract

The identification of antigens that distinguish normal cells from cancer cells is an important challenge in the field of tumour immunology and immunotherapy. The immunoscreening of cDNA expression libraries constructed from human tumour tissues with antibodies in sera from cancer patents (SEREX: serological identification of antigens by recombinant expression cloning) provides a powerful approach to identify immunogenic tumour antigens. To date, over 2,000 tumour antigens have been identified from a variety of malignancies using SEREX. These antigens can be classified into several categories, of which the cancer/testis (CT) antigens appear to be the most attractive candidates for vaccine development. The SEREX-defined tumour antigens facilitate the identification of epitopes (antigenic peptides) recognised by antigen-specific cytotoxic T lymphocytes (CTLs) and provide a basis for peptide vaccine and gene therapy in a wide variety of human cancers. Moreover, some of these antigens seem to play a functional role in the pathogenesis of cancer.

Keywords

Tumour antigen cDNA cloning Serological analysis Antigen identification 

References

  1. 1.
    van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643PubMedGoogle Scholar
  2. 2.
    Boon T, Coulie PG, Van den Eynde B (1997) Tumour antigens recognized by T cells. Immunol Today 18:267PubMedGoogle Scholar
  3. 3.
    Traversari C, van der Bruggen P, Van den Eynde B, Hainaut P, Lemoine C, Ohta N, Old L, Boon T (1992) Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35:145PubMedGoogle Scholar
  4. 4.
    Rotzschke, O, Falk, K, Deres, K, Schild, H, Norda, M, Metzger, J, Jung, G, Rammensee, HG (1990) Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348: 252CrossRefPubMedGoogle Scholar
  5. 5.
    Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L (1994) CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67PubMedGoogle Scholar
  6. 6.
    Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716PubMedGoogle Scholar
  7. 7.
    Clark RE, Dodi IA, Hill SC, Lill JR, Aubert G, Macintyre AR, Rojas J, Bourdon A, Bonner PL, Wang L, Christmas SE, Travers PJ, Creaser CS, Rees RC, Madrigal JA (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 98:2887CrossRefPubMedGoogle Scholar
  8. 8.
    Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS (1963) Production of embryonal alphaglobulin by transplantable mouse hepatomas. Transplantation 1:174Google Scholar
  9. 9.
    Gold P, Freedman SO (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122:467PubMedGoogle Scholar
  10. 10.
    Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495PubMedGoogle Scholar
  11. 11.
    Sell S (1990) Cancer-associated carbohydrates identified by monoclonal antibodies. Hum Pathol 21:1003PubMedGoogle Scholar
  12. 12.
    Masson P, Palsson B, Andren-Sandberg A (1990) Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status. Br J Cancer 62:118PubMedGoogle Scholar
  13. 13.
    Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883PubMedGoogle Scholar
  14. 14.
    Li G, Zhang XY, Fan DM, Hu JL (1994) Detection of antigen-specific immune complexes in sera of gastric and esophageal cancer patients. Chin Med J (Engl) 107:189Google Scholar
  15. 15.
    Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A 92:11810PubMedGoogle Scholar
  16. 16.
    Sahin U, Li G, Tureci O, Pfreundschuh M (2001) Recognition of human tumours: SEREX expression cloning to identify tumour antigens. In: Robins RA, Rees RC (eds) Cancer immunology, immunology and medicine series. Kluwer, Dordrecht, p 45Google Scholar
  17. 17.
    Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 187:1349PubMedGoogle Scholar
  18. 18.
    Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 94:1914CrossRefPubMedGoogle Scholar
  19. 19.
    Line A, Stengrevics A, Slucka Z, Li G, Jankevics E, Rees RC (2002) Serological identification and expression analysis of gastric cancer-associated genes. Br J Cancer 86:1824PubMedGoogle Scholar
  20. 20.
    Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76:652PubMedGoogle Scholar
  21. 21.
    Line A, Slucka Z, Stengrevics A, Silina K, Li G, Rees RC (2002) Characterisation of tumour-associated antigens in colon cancer. Cancer Immunol Immunother 51:574CrossRefPubMedGoogle Scholar
  22. 22.
    Gure AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ, Chen YT (1998) Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res 58:1034PubMedGoogle Scholar
  23. 23.
    Gure AO, Stockert E, Scanlan MJ, Keresztes RS, Jager D, Altorki NK, Old LJ, Chen YT (2000) Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A 97:4198CrossRefPubMedGoogle Scholar
  24. 24.
    Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT (2001) Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 61:2055PubMedGoogle Scholar
  25. 25.
    Obata Y, T Akahashi T, Tamaki H, Tominaga S, Murai H, Iwase T, Iwata H, Mizutani M, Chen YT, Old LJ, Miura S (1999) Identification of cancer antigens in breast cancer by the SEREX expression cloning method. Breast Cancer 6:305PubMedGoogle Scholar
  26. 26.
    Zhou Y, Toth M, Hamman MS, Monahan SJ, Lodge PA, Boynton AL, Salgaller ML (2002) Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line. Biochem Biophys Res Commun 290:830CrossRefPubMedGoogle Scholar
  27. 27.
    Guinn BA, Collin JF, Li G, Rees RC, Mufti GJ (2002) Optimised SEREX technique for the identification of leukaemia-associated antigens. J Immunol Methods 264:207CrossRefPubMedGoogle Scholar
  28. 28.
    Krackhardt AM, Witzens M, Harig S, Hodi FS, Zauls AJ, Chessia M, Barrett P, Gribben JG (2002) Identification of tumour-associated antigens in chronic lymphocytic leukemia by SEREX. Blood 100:2123CrossRefPubMedGoogle Scholar
  29. 29.
    Preuss KD, Zwick C, Bormann C, Neumann F, Pfreundschuh M (2002) Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev 188:43CrossRefPubMedGoogle Scholar
  30. 30.
    Wang RF, Wang X, Atwood AC, Topalian SL, Rosenberg SA (1999) Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Science 284:1351CrossRefPubMedGoogle Scholar
  31. 31.
    Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Buschenfelde KH, Beach D (1995) A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281PubMedGoogle Scholar
  32. 32.
    Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K (1995) Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 55:3478PubMedGoogle Scholar
  33. 33.
    Dhodapkar MV, Osman K, Teruya-Feldstein J, Filippa D, Hedvat CV, Iversen K, Kolb D, Geller MD, Hassoun H, Kewalramani T, Comenzo RL, Coplan K, Chen YT, Jungbluth AA (2003) Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. Cancer Immun 3:9PubMedGoogle Scholar
  34. 34.
    Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188:22CrossRefPubMedGoogle Scholar
  35. 35.
    Schmits R, Cochlovius B, Treitz G, Regitz E, Ketter R, Preuss KD, Romeike BF, Pfreundschuh M (2002) Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer 98:73CrossRefPubMedGoogle Scholar
  36. 36.
    Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W (1995) Immunity to oncogenic proteins. Immunol Rev 145:33PubMedGoogle Scholar
  37. 37.
    Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS (1998) Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A 95:7608CrossRefPubMedGoogle Scholar
  38. 38.
    Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E (1997) Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 6:33CrossRefPubMedGoogle Scholar
  39. 39.
    Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76:652PubMedGoogle Scholar
  40. 40.
    Line A, Slucka Z, Stengrevics A, Li G, Rees RC (2002) Altered splicing pattern of TACC1 mRNA in gastric cancer. Cancer Genet Cytogenet 139:78CrossRefPubMedGoogle Scholar
  41. 41.
    Skipper JC, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, Chen Y, Shabanowitz J, Wolfel T, Slingluff CL Jr, Boon T, Hunt DF, Engelhard VH (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183:527PubMedGoogle Scholar
  42. 42.
    Toh Y, Oki E, Oda S, Tokunaga E, Ohno S, Maehara Y, Nicolson GL, Sugimachi K (1997) Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74:459PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Geng Li
    • 1
  • Amanda Miles
    • 1
  • Aija Line
    • 2
  • Robert C Rees
    • 1
  1. 1.School of ScienceThe Nottingham Trent UniversityNottinghamUK
  2. 2.Biomedical Research and Study CentreUniversity of LatviaRigaLatvia

Personalised recommendations